grants_govRFA-AI-27-014
Open
Development of Candidate Medical Countermeasures (MCMs) and Technologies Against Radiological/Nuclear or Chemical Threats (U01 Clinical Trial Not Allowed)
- Response deadline
- Oct 9, 2028 Due in 722 days
- Date posted
- Sep 1, 2026
- Source
- Open notice
Description
The purpose of this notice of funding opportunity (NOFO) is to support research that advances understanding of the natural history of radiation or chemical exposures; develops relevant injury models; identifies and validates diagnostic tools, biomarkers, or triage technologies; and supports the development of effective medical countermeasures (MCMs) to mitigate or treat acute and/or delayed injuries resulting from radiological/nuclear or chemical public health emergencies.
Classifications
- NAICS93.839
Documents (1)
- RFA-AI-27-014-Full-Announcement.htmltext/html;charset=UTF-8132 KBNot yet available
Contacts
Similar contracts
- Intervention Research to Improve Native American Health (R01 Clinical Trial Optional)Due Jan 7, 2027
- NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)Due Jan 7, 2028
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)Due Jan 7, 2028
- Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)Due Dec 23, 2027
- Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)Due Dec 23, 2027
- Chemical Countermeasures Research Program (CCRP) Initiative: Basic Research on The Deleterious Effects of Acute Exposure to Ultra-Potent Synthetic (UPS) Opioids (R01 Clinical Trial Not Allowed)Due Nov 18, 2027